AK Medical Holdings Ltd. (HK:1789)
:1789
Want to see HK:1789 full AI Analyst Report?
Top Page
AK Medical Holdings Ltd.
(1789)
Select Model
Select Model
Rating:70Neutral
Price Target:
HK$7.00
▲(18.44% Upside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by solid financial fundamentals—strong margins and an exceptionally low-leverage balance sheet—tempered by uneven cash-flow conversion. Technical signals are somewhat weak/neutral (sub-50 RSI, low Stoch, below 20-day average), and valuation appears moderate (P/E ~17.3 with a modest ~1.14% yield).
Positive Factors
High profitability margins
Sustained high gross and operating margins indicate durable pricing power and efficient manufacturing in orthopaedic implants. Margins near 60% (gross) and ~23% (EBIT) support internal R&D, product investment and resilient earnings, helping the business absorb moderate volume swings.
Negative Factors
Volatile cash generation
Material swings in operating and free cash flow across years weaken cash-conversion reliability. Inconsistent cash generation complicates multi-year planning for reinvestment, dividend coverage and capital returns, increasing reliance on prudent balance-sheet buffers to fund growth.
Read all positive and negative factors
Positive Factors
Negative Factors
High profitability margins
Sustained high gross and operating margins indicate durable pricing power and efficient manufacturing in orthopaedic implants. Margins near 60% (gross) and ~23% (EBIT) support internal R&D, product investment and resilient earnings, helping the business absorb moderate volume swings.
Read all positive factors
AK Medical Holdings Ltd. (1789) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$6.81B
Dividend Yield1.26%
Average Volume (3M)4.30M
Price to Earnings (P/E)16.9
Beta (1Y)1.04
Revenue Growth10.19%
EPS Growth23.70%
CountryHK
Employees950
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.30
Shares Outstanding1,123,920,300
10 Day Avg. Volume3,969,892
30 Day Avg. Volume4,297,109
Financial Highlights & Ratios
PEG Ratio0.84
Price to Book (P/B)1.97
Price to Sales (P/S)3.87
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.08Price Target Upside36.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)0.36
Revenue Forecast (FY)HK$1.67B
AK Medical Holdings Ltd. Business Overview & Revenue Model
Company Description
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement...
How the Company Makes Money
AK Medical makes money primarily by selling orthopaedic implant products and associated instruments to healthcare providers and distributors. Its core revenue stream comes from joint replacement implants (such as hip and knee systems) supplied for...
AK Medical Holdings Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
88
Very Positive
Cash Flow
66
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.48B | 1.35B | 1.09B | 1.05B | 761.44M |
| Gross Profit | 897.39M | 808.19M | 674.49M | 636.43M | 499.19M |
| EBITDA | 465.33M | 371.66M | 323.34M | 322.87M | 184.33M |
| Net Income | 339.09M | 273.93M | 182.10M | 204.77M | 92.62M |
Balance Sheet | |||||
| Total Assets | 3.66B | 3.34B | 3.00B | 2.77B | 2.61B |
| Cash, Cash Equivalents and Short-Term Investments | 1.47B | 1.05B | 726.67M | 1.04B | 841.13M |
| Total Debt | 144.79M | 99.39M | 84.20M | 38.78M | 41.56M |
| Total Liabilities | 750.15M | 697.21M | 611.12M | 530.73M | 573.73M |
| Stockholders Equity | 2.91B | 2.64B | 2.39B | 2.24B | 2.03B |
Cash Flow | |||||
| Free Cash Flow | 316.09M | 289.11M | -162.14M | 121.20M | 100.39M |
| Operating Cash Flow | 419.03M | 451.07M | 33.94M | 242.92M | 176.62M |
| Investing Cash Flow | -316.18M | -393.35M | -318.15M | -82.29M | -297.10M |
| Financing Cash Flow | -83.26M | -39.43M | -14.02M | -36.80M | -100.70M |
AK Medical Holdings Ltd. Technical Analysis
Negative
5.91
Price Trends
6.34
Negative
6.15
Negative
6.04
Positive
Market Momentum
-0.09
Positive
37.87
Neutral
19.82
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1789, the sentiment is Negative. The current price of 5.91 is below the 20-day moving average (MA) of 6.42, below the 50-day MA of 6.34, and below the 200-day MA of 6.04, indicating a neutral trend. The MACD of -0.09 indicates Positive momentum. The RSI at 37.87 is Neutral, neither overbought nor oversold. The STOCH value of 19.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1789.
AK Medical Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | HK$6.81B | 16.90 | 11.91% | 1.26% | 10.19% | 23.70% | |
68 Neutral | HK$9.20B | 42.46 | 4.02% | ― | 5.10% | -32.48% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$14.78B | 6.01 | 6.07% | ― | -3.62% | ― | |
48 Neutral | HK$26.51B | -89.31 | -52.30% | ― | 114.97% | 63.21% | |
43 Neutral | HK$582.14M | -2.30 | -21.29% | ― | -34.96% | 42.74% | |
42 Neutral | HK$2.43B | -1.03 | -6.63% | ― | -4.38% | ― |
* Healthcare Sector Average
HK:1789
AK Medical Holdings Ltd.
6.07
0.29
5.02%
HK:0853
MicroPort Scientific
7.71
0.85
12.39%
HK:1302
LifeTech Scientific Corporation
2.13
0.55
34.90%
HK:2160
MicroPort CardioFlow Medtech Corp.
1.91
-2.29
-54.52%
HK:2252
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
25.56
9.48
58.96%
HK:2500
Venus Medtech (Hangzhou), Inc. Class H
1.32
-1.29
-49.43%
AK Medical Holdings Ltd. Corporate Events
AK Medical Sets 2026 AGM to Approve Dividend, Board Changes and Capital Mandates
Apr 28, 2026
AK Medical Holdings Ltd. has convened its annual general meeting for 17 June 2026 in Beijing, where shareholders will review the audited consolidated financial statements and related reports for the year ended 31 December 2025, and vote on a propo...
AK Medical Secures New Overseas Robot Orders as Dual-Brand Strategy Lifts Global Reach
Apr 8, 2026
AK Medical announced new overseas orders for its K3 and K3+ intelligent surgical robotic systems, including a recent sales contract for one unit and an indicated follow-on order, alongside several contracts signed from December 2025 to April 2026 ...
AK Medical Delivers Double-Digit Profit Growth on Digital and Overseas Expansion
Mar 25, 2026
AK Medical reported revenue of RMB1.48 billion for 2025, up 10.1% year on year, driven by strong demand for its surgical products amid accelerated import substitution under China’s volume-based procurement policy. The rapid rise in surgeries...
AK Medical Declares Final Dividend for FY2025
Mar 25, 2026
AK Medical Holdings Limited has declared a final ordinary cash dividend of HKD 0.118 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 17 June 2026. The dividend will be paid in Hon...
AK Medical Sets March Board Meeting to Approve 2025 Results and Consider Dividend
Mar 5, 2026
AK Medical Holdings Limited has scheduled a board meeting for 25 March 2026 at its Global Operation Center in Beijing to review and approve the group’s annual results for the financial year ended 31 December 2025. The board will also conside...
AK Medical Shares Added to CSI HK Connect Robotics Thematic Index
Mar 2, 2026
AK Medical Holdings has been added as a constituent stock of the CSI HK Connect Robotics Thematic Index, which tracks 30 robotics-related companies listed in Hong Kong and accessible via Stock Connect. The index includes firms involved in robotic ...
AK Medical Wins New Hospital Tenders and Advances Robotic, Digital Orthopedic Solutions
Feb 9, 2026
AK Medical Holdings has announced that its subsidiary Beijing Yidian Lingdong Technology has won a tender for an orthopedic hip surgery navigation system and other equipment at The First Affiliated Hospital of Zhejiang University School of Medicin...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.